Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Jan 28, 2017 | $25.6B |
| FY2017, ended Feb 3, 2018 | $29.9B |
| FY2018, ended Feb 2, 2019 | $33.8B |
| FY2019, ended Feb 1, 2020 | $39.9B |
| FY2020, ended Jan 30, 2021 | $39.7B |
| FY2021, ended Jan 29, 2022 | $33.6B |
| FY2022, ended Jan 28, 2023 | $40.9B |
| FY2023, ended Feb 3, 2024 | $48.2B |
| FY2024, ended Feb 1, 2025 | $49.5B |
| FY2025, ended Jan 31, 2026 | $60.8B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $80.2B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Jan 28, 2017 | $12.9B |
| FY2017, ended Feb 3, 2018 | $14.1B |
| FY2018, ended Feb 2, 2019 | $15.0B |
| FY2019, ended Feb 1, 2020 | $16.0B |
| FY2020, ended Jan 30, 2021 | $12.5B |
| FY2021, ended Jan 29, 2022 | $18.9B |
| FY2022, ended Jan 28, 2023 | $18.7B |
| FY2023, ended Feb 3, 2024 | $20.4B |
| FY2024, ended Feb 1, 2025 | $21.1B |
| FY2025, ended Jan 31, 2026 | $22.8B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $24.5B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $1.12B | $1.26B |
| FY2017, ended Feb 3, 2018 | $1.36B | $1.31B |
| FY2018, ended Feb 2, 2019 | $1.59B | $1.65B |
| FY2019, ended Feb 1, 2020 | $1.66B | $1.62B |
| FY2020, ended Jan 30, 2021 | $85.4M | $1.84B |
| FY2021, ended Jan 29, 2022 | $1.72B | $1.18B |
| FY2022, ended Jan 28, 2023 | $1.51B | $1.04B |
| FY2023, ended Feb 3, 2024 | $1.87B | $1.75B |
| FY2024, ended Feb 1, 2025 | $2.09B | $1.64B |
| FY2025, ended Jan 31, 2026 | $2.15B | $2.21B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $2.66B | $2.79B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Jan 28, 2017 | $1.11B |
| FY2017, ended Feb 3, 2018 | $1.29B |
| FY2018, ended Feb 2, 2019 | $1.41B |
| FY2019, ended Feb 1, 2020 | $1.35B |
| FY2020, ended Jan 30, 2021 | $4.82B |
| FY2021, ended Jan 29, 2022 | $4.92B |
| FY2022, ended Jan 28, 2023 | $4.55B |
| FY2023, ended Feb 3, 2024 | $4.87B |
| FY2024, ended Feb 1, 2025 | $4.73B |
| FY2025, ended Jan 31, 2026 | $4.59B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $4.29B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Jan 28, 2017 | $396M |
| FY2017, ended Feb 3, 2018 | $397M |
| FY2018, ended Feb 2, 2019 | $312M |
| FY2019, ended Feb 1, 2020 | $313M |
| FY2020, ended Jan 30, 2021 | $2.51B |
| FY2021, ended Jan 29, 2022 | $2.45B |
| FY2022, ended Jan 28, 2023 | $2.46B |
| FY2023, ended Feb 3, 2024 | $2.46B |
| FY2024, ended Feb 1, 2025 | $2.21B |
| FY2025, ended Jan 31, 2026 | $1.52B |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $1.02B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 18.5% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Jan 28, 2017 | 392M |
| FY2017, ended Feb 3, 2018 | 379M |
| FY2018, ended Feb 2, 2019 | 368M |
| FY2019, ended Feb 1, 2020 | 356M |
| FY2020, ended Jan 30, 2021 | 357M |
| FY2021, ended Jan 29, 2022 | 351M |
| FY2022, ended Jan 28, 2023 | 342M |
| FY2023, ended Feb 3, 2024 | 335M |
| FY2024, ended Feb 1, 2025 | 329M |
| FY2025, ended Jan 31, 2026 | 322M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | 319M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Jan 28, 2017 | $700M | $74.6M |
| FY2017, ended Feb 3, 2018 | $875M | $87.4M |
| FY2018, ended Feb 2, 2019 | $1.07B | $95.6M |
| FY2019, ended Feb 1, 2020 | $1.27B | $95.4M |
| FY2020, ended Jan 30, 2021 | $132M | $102M |
| FY2021, ended Jan 29, 2022 | $650M | $134M |
| FY2022, ended Jan 28, 2023 | $950M | $122M |
| FY2023, ended Feb 3, 2024 | $950M | $145M |
| FY2024, ended Feb 1, 2025 | $1.05B | $156M |
| FY2025, ended Jan 31, 2026 | $1.05B | $175M |
| Trailing 12 months to Aug 1, 2026 (through Q2 FY2026) | $1.16B | $198M |
Valuation
At current price- Market Cap
- $73.5B
- P/E
- 27.6×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.0×
- Price / Book
- 10.9×
- EV / EBITDA
- 18.0×
Growth
Trailing 12 months- Revenue (TTM)
- $24.5B
- Revenue Growth YoY
- 14.0%
- Revenue CAGR 3Y
- 6.8%
- Revenue CAGR 5Y
- 12.7%
- EPS Growth YoY
- 31.3%
- Net Income Growth YoY
- 28.9%
Profitability
Trailing 12 months- Gross Margin
- 29.7%
- Operating Margin
- 13.7%
- Net Margin
- 10.8%
- FCF Margin
- 11.4%
- Return on Equity
- 42.6%
Earnings
Trailing 12 months- Net Income
- $2.66B
- EPS (diluted)
- $8.27
- EBITDA
- $3.91B
- Operating Income
- $3.37B
Balance Sheet
As of Aug 1, 2026- Cash and cash equivalents
- $4.29B
- Total Debt
- $1.02B
- Net Cash
- $3.27B
- Total Assets
- $16.0B
- Total Liabilities
- $9.24B
- Shareholders' Equity
- $6.74B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.66B
- Capital Expenditure
- $870M
- Free Cash Flow
- $2.79B
Dividends and risk
Last 12 months- Dividend Yield
- 0.8%
- Dividend / Share
- $1.74
- Beta (5Y)
- 0.83
Every ratio is calculated from the company’s reported figures.